4/A
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-16-019280
Options or other derivatives
- President and CEO acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brady Todd C President and CEO | 2016-03-16 | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | D | ||
Loading xslF345X03/doc4a.xml…